 | | | | German lawmakers are due to debate introducing a bill making vaccination against COVID-19 mandatory. The idea is facing resistance from politicians as well as ordinary Germans. | | | | | | U.S. financial contributions to the World Health Organization (WHO) have fallen by 25% during the coronavirus pandemic, provisional data show, with Washington's future support to the United Nations agency under review. | | | | | | The Omicron variant appears to result in less severe COVID-19 than seen during previous periods of high coronavirus transmission including the Delta wave, with shorter hospital stays, less need for intensive care and fewer deaths, according to a new U.S. study. | | | | | | National Guard members in New Mexico have begun substitute teaching and the governor said she would do the same in a bid to keep students in classrooms during a COVID-19 surge. | | | | | | French label Stéphane Rolland returned to the runway on Tuesday for the first time since the coronavirus pandemic began, offering an array of feminine draped dresses and billowing cloud-like gowns at Paris Fashion Week. | | | | | | Malta will start to scrap a requirement for people to present a COVID-19 vaccination certificate for entry to restaurants and other venues from next month, Health Minister Chris Fearne said on Tuesday. | | | | | | The Dutch government will further ease COVID-19 restrictions despite record numbers of coronavirus infections, with restaurants, bars and theatres allowed to re-open starting Wednesday, Prime Minister Mark Rutte said on Tuesday. | | | | | | Older primary school students and high school students in Poland are to move to remote learning, Education Minister Przemysław Czarnek said on Tuesday, as the Omicron coronavirus variant takes hold across the country. | | | | | | Rhode Island on Tuesday reversed course and threw its support behind a $21 billion nationwide settlement it originally declined to back resolving lawsuits alleging that three large drug distributors fueled the deadly U.S. opioid epidemic. | | | | | | Johnson & Johnson on Tuesday forecast as much as $3.5 billion in sales of its COVID-19 vaccine in 2022, a 46% jump for the shot that has fared poorly compared to rivals, and said it would take a more aggressive stance on deals for its medical device unit. | | | | | |
